As of Nov 19, 2026, 2 of 2 active firms rate OM a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
OM EPS & revenue forecast
EPS · NEXT QUARTER
$-0.70
Range $-0.82 – $-0.58 · 2 analysts · -16% YoY
Next period, 2 analysts expect Outset Medical Inc to earn $-0.70 a share (range $-0.82 – $-0.58), versus $-0.83 a year earlier. Full-year consensus is $-2.99, growing to $-2.32 the year after.
REVENUE · NEXT QUARTER
$31.1M
Range $29.8M – $32.4M · 2 analysts · +12% YoY
Revenue is expected to reach $31.1M (range $29.8M – $32.4M), +11.6% year-over-year. Full-year consensus is $127.4M, rising to $139.9M next year.
Top analysts covering Outset Medical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OM.
#1
SS
Shagun Singh
RBC Capital
Neutral
$17.00+459.2% to target
Coverage
—
+ Follow
#2
MT
Marie Thibault
BTIG
Buy
$15.00+393.4% to target
Coverage
—
+ Follow
#3
Rick Wise
Stifel
Buy
$8.00+163.2% to target
Coverage
—
+ Follow
#4
Suraj Kalia
Oppenheimer
Neutral
No targeton OM
Coverage
—
+ Follow
OM stock forecast FAQ
What is OM's average 12-month price target?+
The 2 active firms with a live target average $11.50 for Outset Medical Inc over the next 12 months, ranging from a $15.00 high to a $8.00 low, as of Nov 19, 2026.
Is OM stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for OM?+
The Street-high target is $15.00 (BTIG), and the Street-low is $8.00 (Stifel). The average of all 2 active-firm targets is $11.50.
How many active Wall Street firms cover OM?+
2 active firms have a recognized rating on Outset Medical Inc as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering OM?+
Among analysts who currently cover OM, Shagun Singh of RBC Capital has the strongest overall Quantellect track record. Their current call is Neutral with a $17.00 target.
What is Outset Medical Inc's projected EPS for next quarter?+
The consensus estimate is $-0.70 per share (range $-0.82 – $-0.58) across 2 analysts. Full-year EPS is projected at $-2.99, rising to $-2.32 the following year.
How much revenue is Outset Medical Inc expected to report next quarter?+
Consensus revenue is $31.1M (range $29.8M – $32.4M). Full-year revenue is projected at $127.4M, growing to $139.9M next year.
Have analysts been upgrading or downgrading OM lately?+
As of Nov 19, 2026, 2 of 2 active firms rate OM a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.